Data for ST000344
| Metabolite structure | All data | F1 | F2 |
|---|---|---|---|
| 1_CE (22:1) iSTD | 1033089.00 | 930347.17 | |
| 1_Ceramide C17 iSTD | 105915.17 | 88054.83 | |
| 1_Cholesterol d7 iSTD | 12169.17 | 9096.50 | |
| 1_CUDA (pos) iSTD | 74874.17 | 69056.17 | |
| 1_DG (12:0/12:0/0:0) iSTD | 32300.50 | 14737.17 | |
| 1_DG (18:1/2:0/0:0) iSTD | 78245.17 | 39079.50 | |
| 1_LPC (17:0) iSTD | 237862.50 | 167328.33 | |
| 1_LPE (17:1) iSTD | 21455.83 | 16903.00 | |
| 1_MG (17:0/0:0/0:0) iSTD | 14458.83 | 11420.67 | |
| 1_PC (25:0) iSTD | 43560.17 | 31008.67 | |
| 1_PE (17:0/17:0) iSTD | 81282.00 | 62004.67 | |
| 1_SM (d35:1) iSTD | 142718.83 | 100806.67 | |
| 1_Sphingosine (d17:1) iSTD | 39339.17 | 29064.17 | |
| 1_TG (17:0/17:1/17:0)-d5 iSTD | 118525.00 | 69280.17 | |
| Ceramide (d40:1) | 68703.17 | 37834.00 | |
| Ceramide (d42:1) | 132820.00 | 74793.33 | |
| Ceramide (d42:2) | 117849.00 | 86103.33 | |
| Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0) | 46396.67 | 39883.50 | |
| GlcCer (d40:1) | 25814.50 | 17338.50 | |
| GlcCer (d42:1) | 58294.17 | 40552.50 | |
| GlcCer (d42:2) | 24236.83 | 23564.00 | |
| Lactosylceramide (d18:1/24:1(15Z)) | 25621.00 | 19411.00 | |
| PC (28:0) | 61354.00 | 39914.17 | |
| PC (30:0) | 398205.67 | 301969.33 | |
| PC (30:1) | 144499.67 | 103136.33 | |
| PC (32:1) | 2468443.83 | 1856658.00 | |
| PC (32:3) | 37330.50 | 27403.50 | |
| PC (36:1) | 1885965.33 | 1403367.83 | |
| PC (38:2) | 117095.50 | 119114.67 | |
| PC (38:4) B | 255082.33 | 209178.50 | |
| PC (40:1) | 8901.67 | 7062.50 | |
| PC (40:2) | 9734.33 | 9227.17 | |
| PC (42:1) | 8960.83 | 7059.50 | |
| PC (42:2) | 5747.50 | 5275.50 | |
| PC (p-34:3) or PC (o-34:4) | 15361.33 | 8536.00 | |
| PC (p-36:0) or PC (o-36:1) | 57119.00 | 42979.67 | |
| PC (p-36:1) or PC (o-36:2) | 148796.17 | 146359.00 | |
| PC (p-36:3) or PC (o-36:4) | 43528.33 | 33591.33 | |
| PE (32:1) | 36881.00 | 26478.00 | |
| PE (34:1) | 231917.00 | 173846.67 | |
| PE (34:2) | 58835.67 | 45202.33 | |
| PE (36:1) | 257238.67 | 176267.83 | |
| PE (36:2) | 250506.00 | 327433.50 | |
| PE (p-32:1) oe PE (o-32:2) | 142595.00 | 92664.50 | |
| PE (p-34:1) or PE (o-34:2) | 827815.67 | 603109.33 | |
| PE (p-36:1) or PE (o-36:2) | 288561.83 | 200818.17 | |
| PE (p-36:2) or PE (o-36:3) | 212948.83 | 189676.00 | |
| SM (d34:0) | 324643.83 | 243065.00 | |
| SM (d40:0) | 12295.17 | 6665.00 | |
| SM (d42:0) | 12122.00 | 6382.67 |
Factors:
| F1 | Treatment:Control |
| F2 | Treatment:Lipid Supplement |
